Dithiocarbamates ameliorate the effects of endotoxin in a rabbit model of disseminated intravascular coagulation.
Induction of tissue factor (TF) activity by endotoxin and cytokines is an important mechanism for initiation of disseminated intravascular coagulation (DIC) seen in patients with gram-negative sepsis. Based on data from an in vitro study in which dithiocarbamates abrogated endothelial cell TF activity by inhibition of the NF-kappaB pathway, we investigated whether dithiocarbamates had in vivo activity in an animal model of DIC. Dithiocarbamates ameliorated the adverse clinical and histological effects of endotoxin-induced DIC, including morbidity, hypofibrinogenemia, and target organ damage, especially in the liver and kidney, even when given up to 1 hour after administration of endotoxin. This pilot study confirms the key role of the nuclear factor-kappa beta (NF-kappaB) pathway in induction of TF activity in initiating sepsis-associated DIC and suggests that dithiocarbamates may be useful in treatment of DIC associated with excessive TF expression because of gram-negative sepsis. Additional studies of dithiocarbamates in DIC models are warranted.
Drollinger
A G
AG
Department of Medicine, University of Utah Health Sciences Center, Salt Lake City 84132, USA.
Netser
J C
JC
Rodgers
G M
GM
D000818:Animals; D004195:Disease Models, Animal; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced* / Q000188:drug therapy* / Q000473:pathology; D004731:Endotoxins / Q000494:pharmacology*; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D016328:NF-kappa B / Q000502:physiology; D011817:Rabbits; D013859:Thiocarbamates / Q000494:pharmacology*; D013925:Thromboplastin / Q000235:genetics; D014158:Transcription, Genetic
D004731:Endotoxins; D016328:NF-kappa B; D013859:Thiocarbamates; D005340:Fibrinogen; D013925:Thromboplastin